185 related articles for article (PubMed ID: 33830458)
1. Posaconazole micelles for ocular delivery: in vitro permeation, ocular irritation and antifungal activity studies.
Durgun ME; Kahraman E; Hacıoğlu M; Güngör S; Özsoy Y
Drug Deliv Transl Res; 2022 Mar; 12(3):662-675. PubMed ID: 33830458
[TBL] [Abstract][Full Text] [Related]
2. Optimization and Characterization of Aqueous Micellar Formulations for Ocular Delivery of an Antifungal Drug, Posaconazole.
Durgun ME; Kahraman E; Güngör S; Özsoy Y
Curr Pharm Des; 2020; 26(14):1543-1555. PubMed ID: 32167423
[TBL] [Abstract][Full Text] [Related]
3. Optimization of the Micellar-Based In Situ Gelling Systems Posaconazole with Quality by Design (QbD) Approach and Characterization by In Vitro Studies.
Durgun ME; Mesut B; Hacıoğlu M; Güngör S; Özsoy Y
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335902
[TBL] [Abstract][Full Text] [Related]
4. Zero order delivery of itraconazole via polymeric micelles incorporated in situ ocular gel for the management of fungal keratitis.
Jaiswal M; Kumar M; Pathak K
Colloids Surf B Biointerfaces; 2015 Jun; 130():23-30. PubMed ID: 25889081
[TBL] [Abstract][Full Text] [Related]
5. Voriconazole-Cyclodextrin Supramolecular Ternary Complex-Loaded Ocular Films for Management of Fungal Keratitis.
Suvarna P; Chaudhari P; Birangal S; Mallela LS; Roy S; Koteshwara A; Aranjani JM; Lewis SA
Mol Pharm; 2022 Jan; 19(1):258-273. PubMed ID: 34928610
[TBL] [Abstract][Full Text] [Related]
6. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization.
Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH
Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672
[TBL] [Abstract][Full Text] [Related]
7. Natamycin Ocular Delivery: Challenges and Advancements in Ocular Therapeutics.
Mascarenhas M; Chaudhari P; Lewis SA
Adv Ther; 2023 Aug; 40(8):3332-3359. PubMed ID: 37289410
[TBL] [Abstract][Full Text] [Related]
8. Optimization of β-cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug.
Sayed S; Elsayed I; Ismail MM
Int J Pharm; 2018 Oct; 549(1-2):249-260. PubMed ID: 30077759
[TBL] [Abstract][Full Text] [Related]
9. Voriconazole Ternary Micellar Systems for the Treatment of Ocular Mycosis: Statistical Optimization and In Vivo Evaluation.
Fahmy AM; Hassan M; El-Setouhy DA; Tayel SA; Al-Mahallawi AM
J Pharm Sci; 2021 May; 110(5):2130-2138. PubMed ID: 33346033
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of Inclusion Complexes in the Dissolvable Microneedle Ocular Patch System for the Efficiency of Fluconazole in the Therapy of Fungal Keratitis.
Mahfufah U; Sya'ban Mahfud MA; Saputra MD; Abd Azis SB; Salsabila A; Asri RM; Habibie H; Sari Y; Yulianty R; Alsayed AR; Pamornpathomkul B; Mir M; Permana AD
ACS Appl Mater Interfaces; 2024 May; 16(20):25637-25651. PubMed ID: 38728098
[TBL] [Abstract][Full Text] [Related]
11. Ocular toxicity assessment of nanoemulsion in-situ gel formulation of fluconazole.
Samimi MS; Mahboobian MM; Mohammadi M
Hum Exp Toxicol; 2021 Dec; 40(12):2039-2047. PubMed ID: 34036827
[TBL] [Abstract][Full Text] [Related]
12. Fabrication of a drug delivery system that enhances antifungal drug corneal penetration.
Li J; Li Z; Liang Z; Han L; Feng H; He S; Zhang J
Drug Deliv; 2018 Nov; 25(1):938-949. PubMed ID: 29658325
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Ocular Irritation and Bioavailability of Voriconazole Loaded Microemulsion.
Kumar R; Sinha VR
Curr Drug Deliv; 2017; 14(5):718-724. PubMed ID: 27538459
[TBL] [Abstract][Full Text] [Related]
14. Cyclodextrin⁻Amphiphilic Copolymer Supramolecular Assemblies for the Ocular Delivery of Natamycin.
Lorenzo-Veiga B; Sigurdsson HH; Loftsson T; Alvarez-Lorenzo C
Nanomaterials (Basel); 2019 May; 9(5):. PubMed ID: 31096569
[TBL] [Abstract][Full Text] [Related]
15. Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis.
Roy G; Galigama RD; Thorat VS; Mallela LS; Roy S; Garg P; Venuganti VVK
Int J Pharm; 2019 Dec; 572():118808. PubMed ID: 31678387
[TBL] [Abstract][Full Text] [Related]
16. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
Fu T; Yi J; Lv S; Zhang B
J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of ocular toxicity of fluconazole and voriconazole eyedrops using HET-CAM].
Fernández-Ferreiro A; González Barcia M; Gil Martínez M; Blanco Mendez J; Lamas Díaz MJ; Otero Espinar FJ
Farm Hosp; 2014 Jul; 38(4):300-4. PubMed ID: 25137163
[TBL] [Abstract][Full Text] [Related]
18. Implementing polymeric pseudorotaxanes for boosting corneal permeability and antiaspergillus activity of tolnaftate: formulation development, statistical optimization, ex vivo permeation and in vivo assessment.
Aziz D; Mohamed S; Tayel S; Makhlouf A
Drug Deliv; 2022 Dec; 29(1):2162-2176. PubMed ID: 35815689
[TBL] [Abstract][Full Text] [Related]
19. Micelles of Progesterone for Topical Eye Administration: Interspecies and Intertissues Differences in Ex Vivo Ocular Permeability.
Alambiaga-Caravaca AM; Calatayud-Pascual MA; Rodilla V; Concheiro A; López-Castellano A; Alvarez-Lorenzo C
Pharmaceutics; 2020 Jul; 12(8):. PubMed ID: 32722548
[TBL] [Abstract][Full Text] [Related]
20. Reduced administration frequency for the treatment of fungal keratitis: a sustained natamycin release from a micellar solution.
Guo Y; Karimi F; Fu Q; G Qiao G; Zhang H
Expert Opin Drug Deliv; 2020 Mar; 17(3):407-421. PubMed ID: 32009483
[No Abstract] [Full Text] [Related]
[Next] [New Search]
